Ilmodol Dolori Articolari E Muscolari (Diclofenac Epolamine)

Diclofenac epolamine works by inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 (COX‑1 and COX‑2) enzymes in peripheral tissues. This inhibition lowers prostaglandin production, which are mediators of inflammation and pain, thereby providing localized anti‑inflammatory and analgesic effects when applied to the skin.

The appropriate dose of Ilmodol Dolori Articolari E Muscolari is determined by the prescribing healthcare professional. The prescriber will consider the severity of pain, the size of the area to be treated and any relevant patient factors before recommending the amount and frequency of application.

Safety of topical diclofenac during pregnancy or lactation has not been definitively established. Healthcare providers generally advise caution and may recommend alternative therapies, especially in the first trimester or when breastfeeding, to avoid potential risks to the fetus or infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ilmodol contains diclofenac epolamine, a potent NSAID that offers rapid skin penetration and strong anti‑inflammatory activity. Compared with other topical NSAIDs such as ibuprofen or ketoprofen gels, diclofenac epolamine often provides quicker onset of pain relief, though individual response and tolerability may vary.

Ilmodol should be stored at room temperature, ideally below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability.

The gel or cream is applied to clean, dry skin over the painful area. A thin layer is spread gently and massaged until fully absorbed. The exact amount and frequency should follow the prescribing clinician’s instructions, typically not exceeding the recommended surface area per dose.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and systemic NSAID effects like gastrointestinal bleeding, renal impairment, or cardiovascular events. Patients should seek immediate medical attention if they notice signs of a serious reaction.

Ilmodol should be avoided by individuals with known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation. It is also contraindicated on broken, infected or inflamed skin, and should be used with caution in patients with a history of gastrointestinal ulcers, renal disease, or cardiovascular disorders.